Atlas Trials

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

Clinical trial NCT00728000 · WITHDRAWN

Trial details

NCT number
NCT00728000
Sponsor
University of Cincinnati
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2008-08-01
Primary completion
2009-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.